CompuMed (OTCMKTS:CMPD) Stock Price Up 7.1% – Time to Buy?

CompuMed Inc. (OTCMKTS:CMPD)’s stock price was up 7.1% during mid-day trading on Monday . The company traded as high as $5.95 and last traded at $5.55. Approximately 7,202 shares were traded during trading, an increase of 198% from the average daily volume of 2,417 shares. The stock had previously closed at $5.18.

CompuMed Trading Up 3.0%

The company has a debt-to-equity ratio of 0.16, a current ratio of 2.28 and a quick ratio of 2.26. The company has a market capitalization of $8.22 million, a price-to-earnings ratio of -123.54 and a beta of -0.30. The business’s 50-day moving average price is $4.58 and its two-hundred day moving average price is $3.94.

CompuMed (OTCMKTS:CMPD) last announced its quarterly earnings data on Friday, February 13th. The company reported $0.02 earnings per share (EPS) for the quarter. The firm had revenue of $2.10 million for the quarter. CompuMed had a negative net margin of 0.78% and a negative return on equity of 1.82%.

CompuMed Company Profile

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.